Torthaí cuardaigh - Yathushan Yogeswaran
- 1 - 2 toradh as 2 á dtaispeáint
-
1
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomi... de réir Wei Shen Tan, Aaron Prendergast, Charlotte Ackerman, Yathushan Yogeswaran, Joanne Cresswell, Paramananthan Mariappan, Jaspal Phull, Paul Hunter-Campbell, Henry Lazarowicz, Vibhash Mishra, Abhay Rané, Melissa Davies, Hazel Warburton, Peter Cooke, Hugh Mostafid, Daniel Wilby, Robert Mills, Rami Issa, John D. Kelly
Foilsithe / Cruthaithe 2022Artigo -
2
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer de réir Hemant M. Kocher, Bristi Basu, Fieke E. M. Froeling, Debashis Sarker, Sarah Slater, Dominic Carlin, Nandita M. deSouza, Katja N. De Paepe, Michelle R. Goulart, Christine S. Hughes, Ahmet Imrali, Rhiannon Roberts, Maria Pawula, Richard Houghton, Cheryl Lawrence, Yathushan Yogeswaran, Kelly Mousa, Carike Coetzee, Peter Sasieni, Aaron Prendergast, David Propper
Foilsithe / Cruthaithe 2020Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Cancer
Internal medicine
Medicine
Bladder cancer
Chemotherapy
Clinical endpoint
Confidence interval
Cystoscopy
Environmental health
Gemcitabine
Hazard ratio
Intention-to-treat analysis
Log-rank test
Mitomycin C
Oncology
Paclitaxel
Pancreatic cancer
Pharmacodynamics
Pharmacokinetics
Pharmacology
Population
Proportional hazards model
Randomized controlled trial
Stromal cell
Surgery
Urinary system
Urology